PRESS RELEASE
Bloomberg (THEON:NA) / Reuters (THEON.AS)
17 June 2026 – Theon International Plc (THEON) announces that it has entered into an exclusivity agreement with Carlyle for the acquisition of SAS Stéropès, the holding company of SAS HGH Systèmes Infrarouges (HGH) for an enterprise value of approximately €300 million.
Read more at globenewswire.comThis article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.